Targeted LNP Delivery Materials

How this supports a project

A targeted LNP specification must connect the targeting hypothesis to a defined ligand, attachment chemistry, lipid anchor, spacer, formulation ratio, and experimental confirmation plan.

A targeting label is a hypothesis, not a result

Adding a targeting ligand or supplemental lipid can change particle properties, protein interactions, cellular uptake, and organ distribution. The effect depends on the complete formulation, ligand presentation, administration route, dose, and model; the presence of a ligand alone does not demonstrate selective delivery.

The ligand-lipid material should therefore be specified together with an untargeted reference formulation and a biological test plan. Ligand identity, anchor, spacer, surface availability, and incorporation level are formulation variables rather than descriptive labels.

Typical material-planning workflow

Define the targeting hypothesis

State the intended receptor, cell or tissue, supporting evidence, administration route, and assay that will distinguish functional delivery from particle uptake.

Select the ligand and attachment site

Record the ligand identity, functional group available for coupling, orientation constraints, and any activity-sensitive region.

Design the ligand-lipid conjugate

Define the lipid anchor, PEG or other spacer, terminal handle, conjugation reaction, and purification or identity method.

Set the formulation variables

Specify the base LNP composition, ligand-lipid molar percentage, incorporation route, RNA cargo, mixing conditions, and matched control.

Confirm the particle and ligand

Measure particle size, dispersity, encapsulation, lipid identity, ligand incorporation, free ligand, and stability as appropriate to the study.

Test targeting experimentally

Compare functional cargo delivery and off-target distribution against the matched untargeted formulation in the relevant model.

What to define before an inquiry

Target and evidence

Identify the receptor or delivery hypothesis and the model used to test it; a tissue name alone is not enough.

Ligand structure and coupling handle

Provide the full ligand identity, available functional group, conjugation position, and any orientation requirement.

Anchor and spacer design

Specify lipid anchor, PEG length or alternative spacer, linkage type, and expected stability under formulation and storage conditions.

Base formulation and ligand density

Record all lipid identities and ratios, the ligand-lipid percentage, and an otherwise matched untargeted control.

Physical and biological endpoints

Separate particle-quality measurements, binding or uptake assays, functional cargo delivery, and biodistribution measurements.

Application boundary

This page covers material definitions for targeted-LNP research. It does not claim that a listed ligand reaches a tissue, crosses a biological barrier, or improves efficacy or safety. Targeting must be demonstrated for the complete formulation in the intended experimental context.

Related catalog and technical pages

LNP and delivery lipidsBrowse ionizable lipid analogs, PEG lipids, helper phospholipids, sterols, and functional delivery-lipid tools.Lipid materials for deliveryReview how lipid identity, anchors, spacers, and ligand-lipid conjugates are organized on the site.Conjugation chemistry and linkersReview functional handles, spacer design, and stable linkage questions for ligand-lipid preparation.Extrahepatic deliveryReview the evidence and material questions that arise when a project proposes delivery beyond liver-directed systems.PEG-lipid selectionReview PEG chain, lipid anchor, incorporation level, and particle-property questions relevant to surface presentation.